Introducing the Academy’s new CEO

Welcoming Catherine Luckin as the Academy’s new CEO.

The Board is pleased to announce that Catherine Luckin will be joining the Academy as the CEO, starting May 28th.

Catherine Luckin has a decade of experience supporting research and innovation, particularly in the health and medical sciences – through roles in policy, public affairs, strategy and international relations. Until December 2016, she was Head of International at the Academy of Medical Sciences (AMS), the UK’s National Academy for health and medical research. She led a team of staff to deliver initiatives designed to respond to global health challenges, influence policy and promote international mobility, connections and capacity building.

Since arriving in Australia in January 2017, Catherine has held roles in the University of Sydney’s Office of Global Engagement and managing health strategy at the University of Technology Sydney. She brings cross-sector experience, including time spent working in Public Affairs at Pfizer and as Senior Policy Adviser to the Royal College of Physicians of London.

Catherine’s policy experience has covered national and international issues, including: integrating research into health systems; the use of data in research; research careers; immigration and mobility; global health issues; and emerging technologies. She led the AMS’ work on improving the reproducibility of biomedical research, which resulted in an international statement from the InterAcademy Panel that was supported and promoted by the AAHMS Council.

During her career, Catherine has established and led initiatives in a range of areas, including global programs and funding schemes; often collaborating with partners from Government, industry, higher education, research funders, learned societies and NGOs. Consequently, she brings a global network from the UK, Europe, Australia and Academies across the world. She has a BSc in Natural Sciences and an MSc in Science Communication.

Catherine can be contacted on [email protected].

Share this post


Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.